Meeting the Variant Challenge
Joyce Gresko of Alston & Bird discusses how labs have been meeting the challenge posed by COVID and what they can expect in the next year.
Read MorePosted by Chris Wolski | Feb 18, 2022 | Covid 19 |
Joyce Gresko of Alston & Bird discusses how labs have been meeting the challenge posed by COVID and what they can expect in the next year.
Read MorePosted by Andy Lundin | Feb 18, 2022 | Cancer |
The ACS National Consortium convenes leading organizations dedicated to the safe and equitable recovery of cancer screening and treatment services.
Read MorePosted by Chris Wolski | Feb 17, 2022 | Covid 19 |
Liesbet Lagae, program director of life sciences for imec, discusses how breathalyzer technology could be a diagnostic game changer.
Read MorePosted by Andy Lundin | Feb 17, 2022 | Covid 19 |
Canada is relaxing its more stringent COVID-19 testing protocols for travelers, as cases of infection continue to decline.
Read MorePosted by Andy Lundin | Feb 16, 2022 | Covid 19, Diagnostic Technologies |
To create more accurate and sensitive antibody tests, biologists conducted a study that isolated the coronavirus nucleoprotein in its pure form.
Read More